Risultati della ricerca - Roberto Tolando

CVN293, an Investigational Inhibitor of KCNK13 Targeting NLRP3‐Mediated Neuroinflammation in Neurodegenerative Disease: A Phase 1 Study to Investigate the Safety, Tolerability, and... Autoría: Louise Dickson, Roberto Tolando, Celina Scholl, Michelle Charles, Dino Ossola, Kim Matthews, Graham Scott, Martin Bexon, Jasminne Castricum, Philip Kremer, Craig Thompson, Sagar Vaidaya, Lee A Dawson, Mark Carlton, Nicola Brice